US 10391126
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted A61KA61K40/11A61K40/31
Quick answer
US patent 10391126 (CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA) held by The Board of Regents of the University of Texas System expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/421